1 Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a standard class of medications that are used to treat type 2 diabetes mellitus (T2DM) (Collins and Costello, 2024) These medications mimic the actions of a hormone naturally found in the intestines, glucagon-like peptide-1 (GLP-1), which regulates blood sugar levels by increasing insulin secretion and decreasing glucagon release
However, this process takes time - most women undergoing metformin therapy need about 4 to 6 months of consistent treatment to achieve regular ovulatory menstrual cycles
Thin tissue is more susceptible to an overgrowth of bacteria and fungus, resulting in angular cheilitis
Similar to adults, serious side effects in pediatric studies were not significant
GLP-1 receptor agonistsan increasingly popular class of medicationshave become a game-changer for those struggling with excess weight
After 24 h, cells were stimulated with MG132 (10 M) for 8 h at 37 C and then suspended and washed three times with PBS